Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Development and validation of a modified albumin-bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab.
Hatanaka T, Kakizaki S, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Shimada N, Kawata K, Kosaka H, Tanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Kumada T; Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hatanaka T, et al. Among authors: tani j. Hepatol Int. 2023 Feb;17(1):271-273. doi: 10.1007/s12072-022-10446-0. Epub 2022 Nov 16. Hepatol Int. 2023. PMID: 36385371 No abstract available.
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H, Kato K, Iwama H, Maeda E, Sakamoto T, Fujita K, Toyota Y, Tani J, Nomura T, Mimura S, Kobayashi M, Morishita A, Kobara H, Mori H, Yoneyama H, Deguchi A, Himoto T, Kurokohchi K, Okano K, Suzuki Y, Murao K, Masaki T. Miyoshi H, et al. Among authors: tani j. Int J Oncol. 2013 Dec 30. doi: 10.3892/ijo.2013.2233. Online ahead of print. Int J Oncol. 2013. PMID: 24378856
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H, Kato K, Iwama H, Maeda E, Sakamoto T, Fujita K, Toyota Y, Tani J, Nomura T, Mimura S, Kobayashi M, Morishita A, Kobara H, Mori H, Yoneyama H, Deguchi A, Himoto T, Kurokohchi K, Okano K, Suzuki Y, Murao K, Masaki T. Miyoshi H, et al. Among authors: tani j. Int J Oncol. 2014 Jul;45(1):322-32. doi: 10.3892/ijo.2014.2419. Epub 2014 May 6. Int J Oncol. 2014. PMID: 24806290
Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo.
Fujita K, Iwama H, Sakamoto T, Okura R, Kobayashi K, Takano J, Katsura A, Tatsuta M, Maeda E, Mimura S, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Yamana Y, Himoto T, Okano K, Suzuki Y, Niki T, Hirashima M, Masaki T. Fujita K, et al. Among authors: tani j. Int J Oncol. 2015;46(6):2419-30. doi: 10.3892/ijo.2015.2941. Epub 2015 Mar 30. Int J Oncol. 2015. PMID: 25823465
Galectin-9: An anticancer molecule for gallbladder carcinoma.
Tadokoro T, Morishita A, Fujihara S, Iwama H, Niki T, Fujita K, Akashi E, Mimura S, Oura K, Sakamoto T, Nomura T, Tani J, Miyoshi H, Yoneyama H, Himoto T, Hirashima M, Masaki T. Tadokoro T, et al. Among authors: tani j. Int J Oncol. 2016 Mar;48(3):1165-74. doi: 10.3892/ijo.2016.3347. Epub 2016 Jan 19. Int J Oncol. 2016. PMID: 26797414
Primary hepatic neuroendocrine tumor: A case report.
Morishita A, Yoneyama H, Nomura T, Sakamoto T, Fujita K, Tani J, Miyoshi H, Haba R, Masaki T. Morishita A, et al. Among authors: tani j. Mol Clin Oncol. 2016 Jun;4(6):954-956. doi: 10.3892/mco.2016.822. Epub 2016 Mar 17. Mol Clin Oncol. 2016. PMID: 27284429 Free PMC article.
369 results